Literature DB >> 4593343

Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans.

J W Murphy, J A Gregory, H W Larsh.   

Abstract

This study was undertaken to evaluate the potential of a cryptococcal culture filtrate antigen, cryptococcin C184, for detecting delayed hypersensitivity in Cryptococcus neoformans-injected animals. The antigen was tested on guinea pigs which had received saline or C. neoformans and on animals sensitized to Histoplasma capsulatum, Blastomyces dermatitidis, Candida albicans, or Sporothrix schenckii. A delayed-type hypersensitivity response was elicited by cryptococcin C184 in C. neoformans-injected guinea pigs, whereas no indurations or erythemas were seen at 48 h after skin testing of saline controls or heterologously sensitized guinea pigs. Besides being specific for Cryptococcus, the antigen showed a high degree of sensitivity and was reproducible. Footpad tests were conducted with the antigen on mice which had previously received either 10(5) viable C. neoformans cells or saline. Delayed hypersensitivity was indicated in the C. neoformans-injected mice by the increase in thickness of antigen-injected footpads when compared with the saline-injected footpads. In control mice, antigen- and saline-injected footpads were comparable in thickness 24 h after injection. Mice sensitized to B. dermatitidis were footpad tested with C184, and no cross-reactivity was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4593343      PMCID: PMC414817          DOI: 10.1128/iai.9.2.404-409.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  An antigen for detection of hypersensitivity to Cryptococcus neoformans.

Authors:  S B SALVIN; R F SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1961-11

2.  A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica).

Authors:  J M NEILL; I ABRAHAMS; C E KAPROS
Journal:  J Bacteriol       Date:  1950-02       Impact factor: 3.490

3.  Biological assay of lots of histoplasmin and the selection of a new working lot.

Authors:  L W SHAW; A HOWELL; E S WEISS
Journal:  Public Health Rep       Date:  1950-05-05       Impact factor: 2.792

4.  Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis.

Authors:  I Abrahams
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

5.  Experience with a new skin test antigen prepared from Cryptococcus neoformans.

Authors:  A J Atkinson; J E Bennett
Journal:  Am Rev Respir Dis       Date:  1968-04

6.  Biologic properties of skin test antigens of yeast form Sporotrichum schenckii.

Authors:  H S Nielsen
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

7.  Resistance against Cryptococcus conferred by intracellular bacteria and protozoa.

Authors:  L O Gentry; J S Remington
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

8.  Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans.

Authors:  D M Adamson; G C Cozad
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

9.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

View more
  21 in total

1.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.

Authors:  J W Murphy; F Schafer; A Casadevall; A Adesina
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Induction of antigen-specific T suppressor cells by soluble Paracoccidioides brasiliensis antigen.

Authors:  B E Jimenez-Finkel; J W Murphy
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

5.  Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.

Authors:  J W Murphy; R A Cox
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

6.  Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate.

Authors:  C H Mody; K L Sims; C J Wood; R M Syme; J C Spurrell; M M Sexton
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 7.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

8.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Skin test-active substance prepared from culture filtrate of Fonsecaea pedrosoi.

Authors:  T Iwatsu; M Miyaji; H Taguchi; S Okamoto; N Kurita
Journal:  Mycopathologia       Date:  1979-05-31       Impact factor: 2.574

10.  Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis.

Authors:  M A Dykstra; L Friedman
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.